168 related articles for article (PubMed ID: 22679376)
21. On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier.
Li H; Li M; Chen C; Fan A; Kong D; Wang Z; Zhao Y
Int J Pharm; 2015 Nov; 495(1):572-578. PubMed ID: 26387617
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro evaluation of pH-sensitive PEG-I-dC16 block polymer micelles for anticancer drug delivery.
Rongbin H; Lei X; Ying L; Xiangping D; Xuan C; Lanfang L; Cuiyun Y; Yanming C; Guotao T
J Pharm Pharmacol; 2016 Jun; 68(6):751-61. PubMed ID: 27018539
[TBL] [Abstract][Full Text] [Related]
23. Doxorubicin-loaded poly(ε-caprolactone)-Pluronic micelle for targeted therapy of esophageal cancer.
Dai S; Ye Z; Wang F; Yan F; Wang L; Fang J; Wang Z; Fu Z
J Cell Biochem; 2018 Nov; 119(11):9017-9027. PubMed ID: 30256436
[TBL] [Abstract][Full Text] [Related]
24. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
25. Improving physicochemical properties and doxorubicin cytotoxicity of novel polymeric micelles by poly(ε-caprolactone) segments.
Qiu L; Zhang L; Zheng C; Wang R
J Pharm Sci; 2011 Jun; 100(6):2430-42. PubMed ID: 21491452
[TBL] [Abstract][Full Text] [Related]
26. Codelivery of doxorubicin and camptothecin by dual-responsive unimolecular micelle-based β-cyclodextrin for enhanced chemotherapy.
Gao YE; Bai S; Ma X; Zhang X; Hou M; Shi X; Huang X; Chen J; Wen F; Xue P; Kang Y; Xu Z
Colloids Surf B Biointerfaces; 2019 Nov; 183():110428. PubMed ID: 31415956
[TBL] [Abstract][Full Text] [Related]
27. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
[TBL] [Abstract][Full Text] [Related]
28. Doxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cells.
Diao YY; Li HY; Fu YH; Han M; Hu YL; Jiang HL; Tsutsumi Y; Wei QC; Chen DW; Gao JQ
Int J Nanomedicine; 2011; 6():1955-62. PubMed ID: 21976972
[TBL] [Abstract][Full Text] [Related]
29. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
30. Size-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retention.
Rao J; Mei L; Liu J; Tang X; Yin S; Xia C; Wei J; Wan D; Wang X; Wang Y; Li M; Zhang Z; He Q
Acta Biomater; 2019 Apr; 89():300-312. PubMed ID: 30878446
[TBL] [Abstract][Full Text] [Related]
31. Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles.
Cui C; Xue YN; Wu M; Zhang Y; Yu P; Liu L; Zhuo RX; Huang SW
Biomaterials; 2013 May; 34(15):3858-69. PubMed ID: 23452389
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of triblock copolymeric micelles of δ- valerolactone and poly (ethylene glycol) as a competent vector for doxorubicin delivery against cancer.
Nair K L; Jagadeeshan S; Nair SA; Kumar GS
J Nanobiotechnology; 2011 Sep; 9(1):42. PubMed ID: 21943300
[TBL] [Abstract][Full Text] [Related]
33. Disulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy.
Yu S; Ding J; He C; Cao Y; Xu W; Chen X
Adv Healthc Mater; 2014 May; 3(5):752-60. PubMed ID: 24574261
[TBL] [Abstract][Full Text] [Related]
34. Enhanced transcellular penetration and drug delivery by crosslinked polymeric micelles into pancreatic multicellular tumor spheroids.
Lu H; Utama RH; Kitiyotsawat U; Babiuch K; Jiang Y; Stenzel MH
Biomater Sci; 2015 Jul; 3(7):1085-95. PubMed ID: 26221942
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization, and property of biodegradable PEG-PCL-PLA terpolymers with miktoarm star and triblock architectures as drug carriers.
Zhang Y; Luo S; Liang Y; Zhang H; Peng X; He B; Li S
J Biomater Appl; 2018 Mar; 32(8):1139-1152. PubMed ID: 29298551
[TBL] [Abstract][Full Text] [Related]
36. Nucleolin-Targeting AS1411-Aptamer-Modified Graft Polymeric Micelle with Dual pH/Redox Sensitivity Designed To Enhance Tumor Therapy through the Codelivery of Doxorubicin/TLR4 siRNA and Suppression of Invasion.
Yang S; Ren Z; Chen M; Wang Y; You B; Chen W; Qu C; Liu Y; Zhang X
Mol Pharm; 2018 Jan; 15(1):314-325. PubMed ID: 29250957
[TBL] [Abstract][Full Text] [Related]
37. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.
Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC
Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612
[TBL] [Abstract][Full Text] [Related]
38. Design and Validation of PEG-Derivatized Vitamin E Copolymer for Drug Delivery into Breast Cancer.
Li Y; Liu Q; Li W; Zhang T; Li H; Li R; Chen L; Pu S; Kuang J; Su Z; Zhang Z; He J
Bioconjug Chem; 2016 Aug; 27(8):1889-99. PubMed ID: 27418000
[TBL] [Abstract][Full Text] [Related]
39. Radiosensitivity of quiescent and proliferating cells grown as multicellular tumor spheroids.
Onozato Y; Kaida A; Harada H; Miura M
Cancer Sci; 2017 Apr; 108(4):704-712. PubMed ID: 28135769
[TBL] [Abstract][Full Text] [Related]
40. Effects of Doxorubicin Delivery Systems and Mild Hyperthermia on Tissue Penetration in 3D Cell Culture Models of Ovarian Cancer Residual Disease.
Eetezadi S; De Souza R; Vythilingam M; Lessa Cataldi R; Allen C
Mol Pharm; 2015 Nov; 12(11):3973-85. PubMed ID: 26394060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
